skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: DOAJ Directory of Open Access Journals remove Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Material Type:
Article 		Add to My Research

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

The Lancet (British edition), 2021-01, Vol.397 (10272), p.375-386 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 2589-7500 ;EISSN: 1474-547X ;EISSN: 2589-7500 ;DOI: 10.1016/S0140-6736(20)32714-8 ;PMID: 33485464

Full text available

Citations Cited by
2
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
Material Type:
Article 		Add to My Research

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

The Lancet (British edition), 2018-11, Vol.392 (10159), p.1736-1788 [Peer Reviewed Journal]

2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;ISSN: 2214-109X ;EISSN: 1474-547X ;EISSN: 2214-109X ;DOI: 10.1016/S0140-6736(18)32203-7 ;PMID: 30496103

Full text available

Citations Cited by
3
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region
Material Type:
Article 		Add to My Research

Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region

The Lancet global health, 2024-02, Vol.12 (2), p.e177-e178 [Peer Reviewed Journal]

2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;ISSN: 2214-109X ;EISSN: 2214-109X ;DOI: 10.1016/S2214-109X(23)00600-9 ;PMID: 38245105

Full text available

Citations Cited by
4
Is there hope to reach the Zero by 30 target for dog-mediated human rabies?
Is there hope to reach the Zero by 30 target for dog-mediated human rabies?
Material Type:
Article 		Add to My Research

Is there hope to reach the Zero by 30 target for dog-mediated human rabies?

The Lancet global health, 2023-11, Vol.11 (11), p.e1682-e1683 [Peer Reviewed Journal]

2023 World Health Organization ;ISSN: 2214-109X ;EISSN: 2214-109X ;DOI: 10.1016/S2214-109X(23)00431-X ;PMID: 37776869

Full text available

Citations Cited by
5
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Material Type:
Article 		Add to My Research

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

The Lancet (British edition), 2010-09, Vol.376 (9744), p.886-894 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Sep 11-Sep 17, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61259-7 ;PMID: 20801495 ;CODEN: LANCAO

Full text available

Citations Cited by
6
Bednets and malaria in Africa
Bednets and malaria in Africa
Material Type:
Article 		Add to My Research

Bednets and malaria in Africa

Malawi medical journal, 2001-04, Vol.357 (9264), p.1219-1220 [Peer Reviewed Journal]

2001 Elsevier Ltd ;Copyright Lancet Ltd. Apr 21, 2001 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;EISSN: 1995-7270 ;DOI: 10.1016/S0140-6736(00)04448-2 ;PMID: 11418141 ;CODEN: LANCAO

Full text available

Citations Cited by
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait